In June 2003, the FDA approved the FluMist vaccine for influenza, which is administered by squirting tiny amounts of vaccine into each nostril. This would be a(n) __________ vaccine.
a. inactivated vaccine
b. attenuated vaccine
c. recombinant vaccine
d. acellular vaccine

FluMist is the trade name of the live attenuated influenza vaccine, manufactured by MedImmune. This vaccine is used for the prevention of influenza, also called flu.

It is an attenuated vaccine which is given in the form of nasal spray.

An attenuated vaccine alters the pathogen by reducing its virulence and makes it harmless.

Answer Link

In June 2003, the FDA approved the FluMist vaccine for influenza, which is administered by squirting tiny amounts of vaccine into each nostril. This would be a(n) __________ vaccine. a. inactivated vaccine b. attenuated vaccine c. recombinant vaccine d. acellular vaccine

Respuesta :

Otras preguntas

In June 2003, the FDA approved the FluMist vaccine for influenza, which is administered by squirting tiny amounts of vaccine into each nostril. This would be a(n) __________ vaccine.
a. inactivated vaccine
b. attenuated vaccine
c. recombinant vaccine
d. acellular vaccine